Decreased Levels of Microfibril-Associated Glycoprotein (MAGP)-1 in Patients with Colon Cancer and Obesity Are Associated with Changes in Extracellular Matrix Remodelling
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Objective: The protein microfibril-associated glycoprotein (MAGP)-1 constitutes a crucial extracellular matrix protein. We aimed to determine its impact on visceral adipose tissue (VAT) remodelling during obesity-associated colon cancer (CC).
Methods: Samples obtained from 79 subjects (29 normoponderal (NP) (17 with CC) and 50 patients with obesity (OB) (19 with CC)) were used in the study. Circulating concentrations of MAGP-1 and its gene expression levels () in VAT were analysed. The impact of inflammation-related factors and adipocyte-conditioned media (ACM) on mRNA levels in colon adenocarcinoma HT-29 cells were further analysed. The effects of MAGP-1 in the expression of genes involved in the extracellular matrix (ECM) remodelling and tumorigenesis in HT-29 cells was also explored.
Results: Obesity ( < 0.01) and CC ( < 0.001) significantly decreased gene expression levels in VAT whereas an opposite trend in mRNA levels was observed. Increased mRNA levels of after the stimulation of HT-29 cells with lipopolysaccharide (LPS) ( < 0.01) and interleukin (IL)-4 ( < 0.01) together with a downregulation ( < 0.05) after hypoxia mimicked by CoCl treatment was observed. MAGP-1 treatment significantly enhanced the mRNA levels of the ECM-remodelling genes collagen type 6 α3 chain ( ( < 0.05), decorin () ( < 0.01), osteopontin () ( < 0.05) and ( < 0.05). Furthermore, MAGP-1 significantly reduced ( < 0.05) the gene expression levels of prostaglandin-endoperoxide synthase 2 (/), a key gene controlling cell proliferation, growth and adhesion in CC. Interestingly, a significant decrease ( < 0.01) in the mRNA levels of in HT-29 cells preincubated with ACM from volunteers with obesity compared with control media was observed. The decreased levels of MAGP-1 in patients with obesity and CC together with its capacity to modulate key genes involved in ECM remodelling and tumorigenesis suggest MAGP-1 as a link between AT excess and obesity-associated CC development.
Xie G, Qi T, Yao Y, Feng D, Zhou W Sci Rep. 2024; 14(1):26545.
PMID: 39489826 PMC: 11532506. DOI: 10.1038/s41598-024-77971-w.
MFAP2 promotes HSCs activation through FBN1/TGF-β/Smad3 pathway.
Sun Y, Chen X, Chen L, Bao B, Li C, Zhou Y J Cell Mol Med. 2023; 27(21):3235-3246.
PMID: 37635348 PMC: 10623529. DOI: 10.1111/jcmm.17884.
Zhang H, Shen S, Feng C, Chen G, Wang X Acta Biochim Biophys Sin (Shanghai). 2023; 55(9):1445-1455.
PMID: 37592847 PMC: 10520470. DOI: 10.3724/abbs.2023079.
Navakauskiene R, Zukauskaite D, Borutinskaite V, Bukreieva T, Skliute G, Valatkaite E Front Bioeng Biotechnol. 2023; 11:1140781.
PMID: 37122871 PMC: 10133466. DOI: 10.3389/fbioe.2023.1140781.
Xiong L, Wei Y, Jia Q, Chen J, Chen T, Yuan J J Nanobiotechnology. 2023; 21(1):143.
PMID: 37120534 PMC: 10148416. DOI: 10.1186/s12951-023-01888-1.